Recently, social media lit up with the news that Amazon.com vendors are selling Plan B One-Step emergency contraception for as low as $16.90 plus shipping. We have to ask: How is that possible?
Though the FDA decision to permit generic EC pill manufacturers to sell their products over the counter represents a gain for those with the most access to resources, ultimately the decision reflects pharmaceutical manufacturing companies’ interests, rather than the lives of those most adversely affected by lack of access to EC.
Several developments could help make this the year of the intrauterine device: the Affordable Care Act’s birth control benefit, a new tool that could make insertion easier and less painful, a possible generic IUD arriving on the market, and more.
The Times seems to have gone out of its way to publish a commentary that the paper’s own reporting shows is absolutely false on all counts. This is irresponsible media at its worst.
What is a woman to do if neither her plan A (birth control) nor her plan B (the morning-after pill) worked? Wouldn’t it be great if she had a plan C—a medicine similar to these other pills that would start her period and end her anxieties? Such a thing exists, and it should be available to all women.
The law, which reinstated restrictions lifted by the Obama administration, violates the state’s “single-subject” rule.
A bill in Mississippi would restrict teens’ access to emergency contraception, while proposed legislation in Virginia forbids teens from having oral or anal sex.
It was reported recently that French drug manufacturer HRA Pharma had found that the emergency contraceptive Norlevo, which has a similar chemical makeup to Plan B One-Step, is ineffective for women over 176 pounds. Here’s why I was not surprised.
Right to Life of Michigan’s federal lawsuit adds to a pile of recent court cases challenging whether corporations can refuse to provide employees contraception coverage in employer-sponsored health insurance plans on moral grounds.
A “roving band of feminists” took to the streets, or rather the aisles, in New York City Saturday to protest pharmacies that restrict over-the-counter access to Plan B.